ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Heart Institute Withdraws Sponsorship Of Breast Cancer Prevention Trial

October 27, 1995

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

November 4, 1983

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992